Successful treatment of drug-induced acute liver failure with high-volume plasma exchange

J Clin Apher. 2013 Dec;28(6):430-4. doi: 10.1002/jca.21291. Epub 2013 Aug 7.

Abstract

We report two patients with drug-induced liver injury (DILI)-related acute liver failure (ALF) who were successfully treated with high-volume plasma exchange without liver transplantation. The first patient was a 66-year-old man admitted because of a perforated duodenal ulcer complicated with peritonitis and septic shock. After treatment with multiple antibiotics, the patient developed DILI and ALF. Grade 3 hepatic encephalopathy and profound jaundice were present. Symptoms and signs of ALF improved dramatically after initiation of plasma exchange. The patient was discharged uneventfully. The second patient was a 94-year-old man admitted for treatment of newly diagnosed pulmonary tuberculosis. DILI and ALF developed 5 days after initiation of anti-tuberculosis treatment. Grade 4 hepatic encephalopathy was present. After plasma exchange, the patient's level of consciousness improved dramatically, and he recovered from ALF. These 2 cases show the potential of plasma exchange in the treatment of DILI despite occurrence acute liver failure.

Keywords: acute liver failure; artificial liver support; drug-induced liver injury; plasma exchange.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anastomotic Leak
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Antitubercular Agents / therapeutic use*
  • Chemical and Drug Induced Liver Injury / complications*
  • Cross Infection / etiology
  • Duodenal Ulcer / complications
  • Duodenal Ulcer / surgery
  • Fatal Outcome
  • Hepatic Encephalopathy / diagnosis
  • Hepatic Encephalopathy / etiology
  • Humans
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Liver Failure / etiology
  • Liver Failure / therapy*
  • Male
  • Peritonitis / drug therapy
  • Plasma
  • Plasma Exchange* / methods
  • Plasma Substitutes / therapeutic use
  • Pneumonia / etiology
  • Shock, Septic / drug therapy
  • Tuberculosis, Pulmonary / drug therapy

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes